White Paper: Five “Must Ask” Questions to Find the Right CDMO
Pharmaceutical companies frequently rely on a chain of partners to pull them through the development pipeline. Each link in that chain offers a slice of expertise: API sourcing from one, product development from another, manufacturing from a third. It works – except that every new link introduces more layers of administration, more gaps in knowledge, more time, more spending, more regulatory risk.

What if you could find the expertise you need from a single partner? Download our white paper to learn how to find a smart partner during the selection process.

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service